H.R.1014 - Heart Disease Education, Analysis Research, and Treatment for Women Act

To amend the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to improve the prevention, diagnosis, and treatment of heart disease, stroke, and other cardiovascular diseases in women. view all titles (5)

All Bill Titles

  • Official: To amend the Federal Food, Drug, and Cosmetic Act and the Public Health Service Act to improve the prevention, diagnosis, and treatment of heart disease, stroke, and other cardiovascular diseases in women. as introduced.
  • Short: Heart Disease Education, Analysis Research, and Treatment for Women Act as introduced.
  • Short: HEART for Women Act as introduced.
  • Short: Heart Disease Education, Analysis Research, and Treatment for Women Act as passed house.
  • Short: HEART for Women Act as passed house.

This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.

Bill’s Views

  • Today: 1
  • Past Seven Days: 1
  • All-Time: 5,151
 
Introduced
 
House
Passed
 
Senate
Passes
 
President
Signs
 

 
02/13/07
 
09/25/08
 
 
 
 
 

Sponsor

Representative

Lois Capps

D-CA

View Co-Sponsors (238)
 

Latest Vote

Result: Passed - September 25, 2008

Roll call number 642 in the House

Question: On Motion to Suspend the Rules and Pass, as Amended: H R 1014 Heart Disease Education, Analysis Research, and Treatment for Women Act or the “HEART for Women Act”

 

Official Summary

Heart Disease Education, Analysis Research, and Treatment for Women Act or the HEART for Women Act - (Sec. 2) Amends the Federal Food, Drug, and Cosmetic Act to allow the Secretary of Health and Human Services to deny a new drug application if the application fails to include required infor

Official Summary

Heart Disease Education, Analysis Research, and Treatment for Women Act or the HEART for Women Act -

(Sec. 2)

Amends the Federal Food, Drug, and Cosmetic Act to allow the Secretary of Health and Human Services to deny a new drug application if the application fails to include required information on clinical investigations.Directs the Secretary to require that a new drug application include any clinical data possessed by the applicant that relates to the safety and effectiveness of the drug involved by gender, age, and racial subgroup. (Currently, this is required by regulation.)Requires the Secretary to develop guidance for the staff of the Food and Drug Administration (FDA) to ensure that new drug applications are adequately reviewed to determine whether they include the required clinical data.Authorizes the Secretary to place a clinical hold on an investigation under an investigational new drug application if the sponsor of the investigation fails to meet the requirements of an annual report on the status of each study in progress. Applies provisions relating to clinical data submission for new drug applications to an investigational new drug application, an application for a biologics license for a biological product, an application for premarket approval for a class III device, and an application for investigational use of a device.

(Sec. 3)

Amends the Public Health Service Act to require the Secretary to provide that all nonidentifiable patient safety work product reported to and among the network of patient safety databases be identified by sex.Directs that analyses of national and regional statistics of information reported to and among the network of patient safety databases take into account data that specifically relates to women and any disparities between treatment and the quality of care between males and females.

(Sec. 4)

Requires the Director of the Agency for Healthcare Research and Quality to conduct and support research and support demonstrations to identify and evaluate clinical and organizational strategies to improve the quality of and access to care for women with heart disease, stroke, and other cardiovascular diseases.

(Sec. 5)

Requires the Secretary to develop and distribute to females who are age 65 or older, physicians, and other appropriate health care professionals educational materials relating to the prevention diagnosis and treatment of heart disease, stroke, and cardiovascular diseases in women. Requires the Secretary, acting through the Bureau of Health Professions of the Health Resources and Services Administration, to conduct an education and awareness campaign for physicians and other health care professionals relating to the prevention, diagnosis, and treatment of heart disease, stroke, and other cardiovascular diseases in women.

(Sec. 6)

Expands the grant program authorizing the Secretary, acting through the Director of the Centers for Disease Control and Prevention (CDC), to award grants for preventive health services to all states. (Currently, only three grants may be awarded). Authorizes appropriations for FY2009-FY2013.

...Read the Rest




Vote on This Bill

100% Users Support Bill

2 in favor / 0 opposed
 

Send Your Rep a Letter

about this bill Support Oppose Tracking
Track with MyOC